Home › Funds › Two Sigma Investments › ABUS
Two Sigma Investments position in ABUS
ARBUTUS BIOPHARMA CORP · Health Care
Latest position (Q2 2026)84.99K sh
Reported value held$407.93K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 730.30K | $3.13M | New |
| Q4 2021 | 885.54K | $3.44M | Add |
| Q1 2022 | 119.08K | $355.00K | Reduce |
| Q3 2022 | 24.44K | $47.00K | New |
| Q1 2023 | 369.78K | $1.12M | New |
| Q2 2023 | 61.30K | $141.00K | Reduce |
| Q3 2023 | 25.31K | $51.38K | Reduce |
| Q4 2023 | 203.84K | $509.59K | Add |
| Q1 2024 | 97.92K | $252.62K | Reduce |
| Q2 2024 | 14.89K | $46.00K | Reduce |
| Q3 2024 | 29.73K | $114.44K | Add |
| Q4 2024 | 29.49K | $96.42K | Reduce |
| Q1 2025 | 18.29K | $63.82K | Reduce |
| Q1 2025 | 18.29K | $63.82K | Reduce |
| Q2 2025 | 11.30K | $34.91K | Reduce |
| Q2 2025 | 11.30K | $34.91K | Reduce |
| Q2 2026 | 84.99K | $407.93K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABUS
- Morgan Stanley 17.70M sh · $84.95M · Q2 2026
- BlackRock Inc 13.77M sh · $66.08M · Q2 2026
- Vanguard Group 9.24M sh · $44.46M · Q4 2025
- Geode Capital Management 4.12M sh · $19.77M · Q2 2026
- Goldman Sachs Group 3.51M sh · $16.83M · Q2 2026
- Bank of America Corp 2.65M sh · $12.70M · Q2 2026
- Legal & General Investment Management America 2.47M sh · $11.84M · Q2 2026
- Charles Schwab Investment Management 1.43M sh · $6.87M · Q2 2026
- Northern Trust Corp 1.42M sh · $6.81M · Q2 2026
- Citigroup Inc 879.24K sh · $4.22M · Q2 2026
- Arrowstreet Capital 650.70K sh · $3.12M · Q2 2026
- Wellington Management Group 461.65K sh · $2.22M · Q2 2026